WeVote
Log In

Bill

Bill

SB 734

Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing a fee.

89th Legislature (2025) Introduced by José Menéndez

Texas bill establishes medical cannabis program allowing patient possession and cultivation while creating state licensing system for cannabis businesses and generating regulatory fees.

Referred to Health & Human Services
#crimes--drugs(i0185) #electronicinformationsystems(i0311) #governor(i0375) #health--otherdiseases&medicalconditions(i0383) #marihuana(s3105) #medicine&prescriptiondrugs(s7338) #occupationalregulation--othertrades&professions(i0541) #packaging&labelingrequirements(s0339) #physicians(s1282) #publicsafety #departmentof(v0251) #statefinances--management&control(i0748)
0
WeVote Research Nonpartisan
Bill Summary · SB 734

Legislative bill overview

SB 734 would establish a medical cannabis program in Texas, permitting qualified patients with specified medical conditions to legally possess, use, and cultivate cannabis for medical purposes. The bill also creates a licensing framework for medical cannabis organizations (producers, distributors, retailers) and authorizes the state to collect fees from licensed entities.

Why is this important

Texas currently has only a highly restricted medical cannabis program (Compassionate Use Program) serving fewer than 15,000 patients. This bill would significantly expand access to cannabis as a medical treatment option, potentially benefiting tens of thousands of Texans with conditions like chronic pain, epilepsy, and cancer. The licensing structure would establish state oversight and tax revenue generation while creating a legal market that could reduce illegal activity.

Potential points of contention

  • Qualifying conditions definition: Disagreement over which medical conditions warrant access—broader definitions benefit more patients but raise concerns about gateway use or inadequate medical justification
  • Workplace and impairment standards: Unclear how employers, safety-sensitive positions, and impaired driving enforcement will be regulated, particularly since cannabis impairment testing lacks standardized metrics
  • Federal-state conflict: Cannabis remains federally illegal under Schedule I, creating liability risks for state-licensed businesses and potential conflicts with federal law enforcement

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.